Bio Green Med Solution, Inc. — Director's Dealing 2010

Dec 14, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2010-12-10

Reporting Person: McBarron Paul (Director, EVP, Finance, CFO, COO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-12-10	Option	$1.59	A	75000	Acquired	2020-12-10	Common Stock (75000)	Direct

Footnotes

F1: These options are exercisable over a four-year period, with 1/48 of the options granted vesting on a monthly basis.

F2: These securities were issued as part of the Issuer's annual equity compensation to executive officers.